cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.48597/jueg-h4an
title: Measurement of Cis_NO at Kollumerwaard

description: Measurement of Cis_NO at Kollumerwaard
DOI: 10.48597/jwmc-955b
title: Measurement of Pp_DDE at Giordan Lighthouse

description: Measurement of Pp_DDE at Giordan Lighthouse
DOI: 10.48597/jwtu-t2nr
title: Measurement of PCB_180 at Giordan Lighthouse

description: Measurement of PCB_180 at Giordan Lighthouse
DOI: 10.48597/khfx-4cnt
title: Measurement of Benzo_a_pyrene at Vredepeel

description: Measurement of Benzo_a_pyrene at Vredepeel
DOI: 10.48597/kj34-s4u4
title: Measurement of PCB_101 at Kollumerwaard

description: Measurement of PCB_101 at Kollumerwaard
DOI: 10.48597/m3bp-qu66
title: Measurement of Fluorene at Giordan Lighthouse

description: Measurement of Fluorene at Giordan Lighthouse
DOI: 10.48597/m6er-pjh7
title: Measurement of PCB_101 at Vredepeel

description: Measurement of PCB_101 at Vredepeel
DOI: 10.48597/mbg7-ujnd
title: Measurement of Pp_DDT at Leova

description: Measurement of Pp_DDT at Leova
DOI: 10.48597/mmge-sxyc
title: Measurement of Fluorene at Kollumerwaard

description: Measurement of Fluorene at Kollumerwaard
DOI: 10.48597/ms9z-7agc
title: Measurement of PCB_138 at Birkenes

description: Measurement of PCB_138 at Birkenes
DOI: 10.48597/n59q-7yej
title: Measurement of Phenanthrene at Kollumerwaard

description: Measurement of Phenanthrene at Kollumerwaard
DOI: 10.48597/nvz8-wk5b
title: Measurement of Pp_DDD at Giordan Lighthouse

description: Measurement of Pp_DDD at Giordan Lighthouse
DOI: 10.48597/phnt-kz4k
title: Measurement of PCB_101 at Giordan Lighthouse

description: Measurement of PCB_101 at Giordan Lighthouse
DOI: 10.48597/pjny-w8y2
title: Measurement of Chrysene at Kollumerwaard

description: Measurement of Chrysene at Kollumerwaard
DOI: 10.48597/ptmx-5e3k
title: Measurement of PCB_118 at Vredepeel

description: Measurement of PCB_118 at Vredepeel
DOI: 10.48597/pzbs-trxw
title: Measurement of Cis_CD at Giordan Lighthouse

description: Measurement of Cis_CD at Giordan Lighthouse
DOI: 10.48597/q3km-7nbd
title: Measurement of PCB_118 at Vredepeel

description: Measurement of PCB_118 at Vredepeel
DOI: 10.48597/qgn5-vqga
title: Measurement of PCB_118 at Birkenes

description: Measurement of PCB_118 at Birkenes
DOI: 10.48597/qpzn-25f6
title: Measurement of Gamma_HCH at Kollumerwaard

description: Measurement of Gamma_HCH at Kollumerwaard
DOI: 10.48597/qykq-zfu5
title: Measurement of Op_DDT at Vredepeel

description: Measurement of Op_DDT at Vredepeel
DOI: 10.48597/r4kq-7gjj
title: Measurement of Benzo_a_pyrene at Kollumerwaard

description: Measurement of Benzo_a_pyrene at Kollumerwaard
DOI: 10.48597/r7fz-22ex
title: Measurement of Trans_CD at Vredepeel

description: Measurement of Trans_CD at Vredepeel
DOI: 10.48597/r9qx-nsn9
title: Measurement of PCB_28 at Vredepeel

description: Measurement of PCB_28 at Vredepeel
DOI: 10.48597/s9xg-d7at
title: Measurement of Trans_NO at Vredepeel

description: Measurement of Trans_NO at Vredepeel
DOI: 10.48597/sfuz-6xm6
title: Measurement of Trans_CD at Kollumerwaard

description: Measurement of Trans_CD at Kollumerwaard
DOI: 10.48597/st29-dnwu
title: Measurement of Phenanthrene at Kollumerwaard

description: Measurement of Phenanthrene at Kollumerwaard
DOI: 10.48597/tmjh-eaqc
title: Measurement of Fluoranthene at Giordan Lighthouse

description: Measurement of Fluoranthene at Giordan Lighthouse
DOI: 10.48597/twgh-649v
title: Measurement of PCB_138 at Kollumerwaard

description: Measurement of PCB_138 at Kollumerwaard
DOI: 10.48597/ugqw-mthv
title: Measurement of Pp_DDD at Vredepeel

description: Measurement of Pp_DDD at Vredepeel
DOI: 10.48597/ujfm-hqnp
title: Measurement of Benz_a_anthracene at Vredepeel

description: Measurement of Benz_a_anthracene at Vredepeel
DOI: 10.48597/ux6a-zyem
title: Measurement of Op_DDT at Giordan Lighthouse

description: Measurement of Op_DDT at Giordan Lighthouse
DOI: 10.48597/vcgc-k4ed
title: Measurement of Phenanthrene at Giordan Lighthouse

description: Measurement of Phenanthrene at Giordan Lighthouse
DOI: 10.48597/vgkk-4vts
title: Measurement of PCB_28 at Kollumerwaard

description: Measurement of PCB_28 at Kollumerwaard
DOI: 10.48597/vjcd-wp9u
title: Measurement of Trans_NO at Leova

description: Measurement of Trans_NO at Leova
DOI: 10.48597/vupn-p8jh
title: Measurement of PCB_52 at Birkenes

description: Measurement of PCB_52 at Birkenes
DOI: 10.48597/w6pr-tks8
title: Measurement of Cis_NO at Vredepeel

description: Measurement of Cis_NO at Vredepeel
DOI: 10.48597/wkev-atqq
title: Measurement of Cis_NO at Giordan Lighthouse

description: Measurement of Cis_NO at Giordan Lighthouse
DOI: 10.48597/wm2n-5ucb
title: Measurement of PCB_52 at Kollumerwaard

description: Measurement of PCB_52 at Kollumerwaard
DOI: 10.34740/kaggle/dsv/7783724
title: Indian skincare dataset
DOI: 10.48597/wm97-sp77
title: Measurement of PCB_28 at Birkenes

description: Measurement of PCB_28 at Birkenes
DOI: 10.48597/wthf-y2sn
title: Measurement of PCB_153 at Vredepeel

description: Measurement of PCB_153 at Vredepeel
DOI: 10.48597/wysd-fbyr
title: Measurement of PCB_180 at Birkenes

description: Measurement of PCB_180 at Birkenes
DOI: 10.48597/x4fd-pebq
title: Measurement of Pp_DDE at Vredepeel

description: Measurement of Pp_DDE at Vredepeel
DOI: 10.2908/lfsi_siz_m
title: Taille d’échantillon réalisé – données mensuelles, statistiques expérimentales
title: Realised sample size - monthly data, experimental statistics
title: Realisierte Stichprobengröße - monatliche Daten, experimentelle Statistiken
DOI: 10.48597/xfz7-mvg7
title: Measurement of PCB_180 at Giordan Lighthouse

description: Measurement of PCB_180 at Giordan Lighthouse
DOI: 10.2908/lfsi_abs_w
title: Weekly absences from work, by sex and age - weekly data, experimental statistics
title: Wöchentliche Abwesenheit von der Arbeit nach Geschlecht und Alter - wöchentliche Daten, experimentelle Statistiken
title: Absences du travail hebdomadaires, sexe et groupe d’âge – données hebdomadaires, statistiques expérimentales
DOI: 10.48597/xvzc-gtrv
title: Measurement of Trans_NO at Kollumerwaard

description: Measurement of Trans_NO at Kollumerwaard
DOI: 10.48597/y2yw-rrcp
title: Measurement of Alpha_HCH at Birkenes

description: Measurement of Alpha_HCH at Birkenes
DOI: 10.48597/ys4n-xymd
title: Measurement of PCB_118 at Giordan Lighthouse

description: Measurement of PCB_118 at Giordan Lighthouse
DOI: 10.48597/yvjy-5xav
title: Measurement of PCB_138 at Birkenes

description: Measurement of PCB_138 at Birkenes
DOI: 10.2908/trng_cost01s
title: Cost of CVT courses as % of total labour cost (all enterprises), by type of cost and size class
title: Coûts de la formation professionnelle continue (cours) en % du coût total de la main-d'oeuvre (ensemble des entreprises), par type de coût et par classe de taille
title: Anteil der Kosten für Weiterbildung (Kurse) an den gesamten Arbeitskosten (alle Unternehmen), nach Kostenart und Größenklasse
DOI: 10.48597/z39f-umhm
title: Measurement of Benzo_a_pyrene at Giordan Lighthouse

description: Measurement of Benzo_a_pyrene at Giordan Lighthouse
DOI: 10.2908/trng_cost02n
title: Cost of CVT courses per participant, by type of cost and NACE Rev. 1.1
title: Coûts de la formation professionnelle continue (cours) par participant, par type de coût et par NACE Rév. 1.1
title: Kosten für Weiterbildung (Kurse) je Teilnehmer, nach Kostenart und NACE Rev. 1.1
DOI: 10.2908/trng_cost02s
title: Cost of CVT courses per participant, by type of cost and size class
title: Coûts de la formation professionnelle continue (cours) par participant, par type de coût et par classe de taille
title: Kosten für Weiterbildung (Kurse) je Teilnehmer, nach Kostenart und Größenklasse
DOI: 10.48597/z5dz-4zr8
title: Measurement of Alpha_HCH at Giordan Lighthouse

description: Measurement of Alpha_HCH at Giordan Lighthouse
DOI: 10.2908/trng_cost03s
title: Cost of CVT courses per employee (only enterprises with CVT courses), by type of cost and size class
title: Coûts de la formation professionnelle continue (cours) par salarié (seulement les entreprises offrant des cours de formation professionnelle continue), par type de coût et par classe de taille
title: Kosten für Weiterbildung (Kurse) je Beschäftigter (nur Unternehmen mit Weiterbildungskursen) nach Kostenart und Größenklasse
DOI: 10.2908/trng_cost05
title: Percentage of direct cost of CVT courses, by type of direct cost
title: Pourcentage du coût direct de la formation professionnelle continue (cours), par type de coût direct
title: Prozent der direkten Kosten für Weiterbildung (Kurse), nach direkten Kostenart
DOI: 10.48597/zmqv-r585
title: Measurement of HCB at Vredepeel

description: Measurement of HCB at Vredepeel
DOI: 10.6084/m9.figshare.24297066
title: The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands

description: The effect of a preexisting comorbidity on the occurrence of adverse events after immunization (AEFIs) has been studied poorly. In this longitudinal cohort study, we assess the association between co-morbidities and the occurrence of AEFIs after COVID-19 vaccination. Also, we described the occurrence of flare-ups and their manifestation after COVID-19 vaccination in people with rheumatic diseases. We performed multivariable logistic regression to investigate the association between the occurrence of AEFIs and 10 common comorbidities using patient-reported data from people vaccinated with the AstraZeneca, Johnson&Johnson, Moderna, or Pfizer vaccine. Occurrence of any AEFI, injection site reactions, headache, fatigue, and/or malaise was significantly associated with presence of comorbidities, including psychological disorders, musculoskeletal disorders, and endocrine disorders after the first and second doses (OR ranges 1.23–1.77). One participant with rheumatoid arthritis experienced a flare-up after receiving the first dose of the AstraZeneca vaccine. The results showed that the odds of reporting an AEFI after COVID-19 vaccination is significantly higher in the presence of some comorbidities whilst flare-ups are uncommon after receiving COVID-19 vaccination in people with rheumatic disease. In-depth research is needed to validate our results and unravel the observed associations from a mechanistic perspective.
DOI: 10.6084/m9.figshare.24297066.v1
title: The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands

description: The effect of a preexisting comorbidity on the occurrence of adverse events after immunization (AEFIs) has been studied poorly. In this longitudinal cohort study, we assess the association between co-morbidities and the occurrence of AEFIs after COVID-19 vaccination. Also, we described the occurrence of flare-ups and their manifestation after COVID-19 vaccination in people with rheumatic diseases. We performed multivariable logistic regression to investigate the association between the occurrence of AEFIs and 10 common comorbidities using patient-reported data from people vaccinated with the AstraZeneca, Johnson&Johnson, Moderna, or Pfizer vaccine. Occurrence of any AEFI, injection site reactions, headache, fatigue, and/or malaise was significantly associated with presence of comorbidities, including psychological disorders, musculoskeletal disorders, and endocrine disorders after the first and second doses (OR ranges 1.23–1.77). One participant with rheumatoid arthritis experienced a flare-up after receiving the first dose of the AstraZeneca vaccine. The results showed that the odds of reporting an AEFI after COVID-19 vaccination is significantly higher in the presence of some comorbidities whilst flare-ups are uncommon after receiving COVID-19 vaccination in people with rheumatic disease. In-depth research is needed to validate our results and unravel the observed associations from a mechanistic perspective.
DOI: 10.2908/trng_cost07
title: Structure of costs of CVT courses per employee in enterprises with CVT courses (PPS)
title: Structure des coûts des cours FPC par employé dans les entreprises offrant des cours de FPC (SPA)
title: Kostenstruktur der Weiterbildungskurse je Beschäftigter in Unternehmen mit Weiterbildungskursen (KKS)
DOI: 10.2908/trng_cost08
title: Structure of costs of CVT courses per participant (PPS)
title: Structure des coûts de FPC par participant aux cours (SPA)
title: Kostenstruktur der Weiterbildungskurse je Teilnehmer (KKS)
DOI: 10.2908/trng_cost09n
title: Cost of CVT courses per employee (all enterprises), by type of cost and NACE Rev. 1.1
title: Coûts de la formation professionnelle continue (cours) par salarié (toutes les entreprises), par type de coût et par NACE Rév. 1.1
title: Kosten für Weiterbildungskursen je Beschäftigter (alle Unternehmen) nach Kostenart und NACE Rev. 1.1
DOI: 10.48597/zpwd-7c32
title: Measurement of Alpha_HCH at Giordan Lighthouse

description: Measurement of Alpha_HCH at Giordan Lighthouse
DOI: 10.6084/m9.figshare.24081212
title: A real-world disproportionality analysis of anti-VEGF drugs from the FDA Adverse Event Reporting System

description: The association between anti-vascular endothelial growth factor (VEGF) drugs and ocular adverse events (AEs) has been reported, but large real-world studies of their association with systemic AEs are still lacking. A disproportionality analysis of reports from the FDA Adverse Event Reporting System from January 2004 to September 2021 was conducted to detect the significant ADR signals with anti-VEGF drugs (including aflibercept, bevacizumab, brolucizumab, pegaptanib, and ranibizumab). A total of 2980 reported cases with 7125 drug-AEs were included. Five drugs were all associated with eye disorders, and pegaptanib and ranibizumab were also associated with cardiac disorders. For ranibizumab, pegaptanib, bevacizumab and aflibercept, the proportions of cardiac AEs were 8.57%, 5.62%, 3.43% and 3.20%, respectively, and the proportions of central nervous AEs were 8.81%, 7.41, 5.86% and 5.68%, respectively. In multiple comparisons, ranibizumab was significantly higher than bevacizumab and aflibercept in the proportion of cardiac AEs (<i>P</i> &lt; 0.001), and ranibizumab was significantly higher than aflibercept in central nervous AEs (<i>P</i> &lt; 0.001). Our findings support the associations between anti-VEGF drugs and ocular AEs, cardiac AEs, and central nervous AEs. After intravitreal injection, attention should not only be paid to ocular symptoms, but also to systemic symptoms.
DOI: 10.2908/trng_ent03an
title: Percentage of enterprises providing any other form of training, by form of training and NACE Rev 1.1
title: Pourcentage d'entreprises fournissant une autre forme de formation, par forme de formation et par NACE Rév 1.1
title: Unternehmen mit 'anderen' Weiterbildungsformen nach Weiterbildungsform und NACE Rev 1.1 (%)
DOI: 10.2908/trng_ent03as
title: Percentage of enterprises providing any other form of training, by form of training and size class
title: Pourcentage des entreprises fournissant une autre forme de formation, par forme de formation et par classe de taille
title: Unternehmen mit 'anderen' Weiterbildungsformen nach Weiterbildungsform und Größenklasse (%)
DOI: 10.48597/zq9u-3ctf
title: Measurement of Chrysene at Vredepeel

description: Measurement of Chrysene at Vredepeel
DOI: 10.2908/trng_ent03bs
title: Enterprises providing any other form of training as % of all enterprises, by form of training and size class
title: Entreprises fournissant une autre forme de formation en % de toutes les entreprises, par forme de formation et par classe de taille
title: Unternehmen mit 'anderen' Weiterbildungsformen als Anteil an allen Unternehmen, nach Weiterbildungsform und Größenklasse
DOI: 10.2908/trng_ent03s
title: Training enterprises as % of all enterprises, by type of training and size class
title: Entreprises de formation en % de toutes les entreprises, par type de formation et par classe de taille
title: Weiterbildende Unternehmen als Anteil an allen Unternehmen nach Weiterbildungstyp und Größenklasse (%)
DOI: 10.48597/zztr-3jgu
title: Measurement of Pp_DDD at Leova

description: Measurement of Pp_DDD at Leova
DOI: 10.2908/trng_ent04n
title: Percentage of all enterprises providing CVT courses, by type of course and NACE Rev 1.1
title: Pourcentage de l'ensemble des entreprises fournissant des cours de formation professionnelle continue (cours), par type de cours et NACE Rév 1.1
title: Unternehmen mit Weiterbildungskursen nach Kurstyp und NACE Rev 1.1 (%)
DOI: 10.48597/24my-g9vk
title: Measurement of Pm25_mass at Okefenokee National Wildlife Refuge (GA09)

description: Measurement of Pm25_mass at Okefenokee National Wildlife Refuge (GA09)
DOI: 10.2908/trng_ent05s
title: Percentage of all non-training enterprises, by reason for not providing CVT and size class
title: Pourcentage de l'ensemble des entreprises non formatrices, selon la raison pour laquelle elles ne fournissent pas de cours de formation professionnelle continue et par classe de taille
title: Nicht weiterbildende Unternehmen nach Gründen, keine Weiterbildung durchzuführen, und nach Größenklasse (%)
DOI: 10.2908/trng_ent07s
title: Enterprises assessing the skills and training needs of employees as % of all enterprises, by type of training, type of assessment and size class
title: Entreprises évaluant les qualifications et les besoins de formation des employés en % de l'ensemble des entreprises, par type de formation, par type d'évaluation et par classe de taille
title: Prozentsatz aller Unternehmen festsetzen, nach Weiterbildungstyp, nach Art der Einschätzung und Größenklasse
DOI: 10.48597/26ef-f3ra
title: Measurement of Pm10_mass at Okefenokee National Wildlife Refuge (GA09)

description: Measurement of Pm10_mass at Okefenokee National Wildlife Refuge (GA09)
DOI: 10.48597/2e5m-trpk
title: Measurement of Pm25_mass at Craters of the Moon National Monument (ID03)

description: Measurement of Pm25_mass at Craters of the Moon National Monument (ID03)
DOI: 10.2908/trng_ent08an
title: Enterprises that needed to obtain or develop new skills in the period 1997-1999 by NACE Rev 1.1 and by the main ways used to obtain or develop those new skills (%)
title: Entreprises ayant eu des besoins d'acquisition ou de développement de nouvelles compétences au cours de la période 1997-1999, par catégorie de la NACE Rév 1.1 et par principaux moyens utilisés pour obtenir ou développer ces nouvelles qualifications (en %)
title: Unternehmen, die im Zeitraum 1997-1999 neue Fertigkeiten erwerben oder entwickeln mussten, nach der NACE Rev 1.1 und den wichtigsten Mitteln zum Erwerb oder zur Entwicklung dieser neuen Fertigkeiten (%)
DOI: 10.2908/trng_ent08as
title: Enterprises that needed to obtain or develop new skills in the period 1997-1999 by size and by the main ways used to obtain or develop those new skills (%)
title: Entreprises ayant eu des besoins d'acquisition ou de développement de nouvelles compétences au cours de la période 1997-1999, par classe de taille et par principaux moyens utilisés pour obtenir ou développer ces nouvelles qualifications (en %)
title: Unternehmen, die im Zeitraum 1997-1999 neue Fertigkeiten erwerben oder entwickeln mussten, nach Größe und den wichtigsten Mitteln zum Erwerb oder zur Entwicklung dieser neuen Fertigkeiten (%)
DOI: 10.48597/2r8d-w5ra
title: Measurement of Pm10_mass at Okefenokee National Wildlife Refuge (GA09)

description: Measurement of Pm10_mass at Okefenokee National Wildlife Refuge (GA09)
DOI: 10.2908/trng_ent08n
title: Percentage of enterprises with the need to obtain or develop new skills by NACE Rev. 1.1 activity (1997-1999)
title: Pourcentage des entreprises ayant de besoins d'acquisition ou de développement de nouvelles compétences par activité de la NACE Rév. 1.1 (1997-1999)
title: Prozentsatz der Unternehmen mit Bedarf am Erwerb oder der Entwicklung neuer Fertigkeiten nach NACE Rev. 1.1 Tätigkeit (1997-1999)
DOI: 10.2908/trng_ent10n
title: Percentage of enterprises with a training plan including CVT, by reason for having this plan, by type of training and NACE
title: Pourcentage des entreprises avec un plan de formation comprenant des cours de formation professionnelle continue, selon la raison d'avoir ce plan, par type de formation et par NACE
title: Prozentsatz der Unternehmen mit einem Bildungsplan einschließlich Weiterbildungskursen, nach Grund eines solchen Planes zu besitzen, nach Weiterbildungstyp und NACE
DOI: 10.48597/2xtd-6hej
title: Measurement of Pm25_mass at Everglades National Park-Research Center (FL11)

description: Measurement of Pm25_mass at Everglades National Park-Research Center (FL11)
DOI: 10.48597/2zhr-c4ef
title: Measurement of Pm25_mass at Okefenokee National Wildlife Refuge (GA09)

description: Measurement of Pm25_mass at Okefenokee National Wildlife Refuge (GA09)
DOI: 10.2908/trng_ent10s
title: Percentage of enterprises with a training plan including CVT, by reason for having this plan, by type of training and size class
title: Pourcentage des entreprises avec un plan de formation comprenant des cours de formation professionnelle continue, selon la raison d'avoir ce plan, par type de formation et par classe de taille
title: Prozentsatz der Unternehmen mit einem Bildungsplan einschließlich Weiterbildungskursen, nach Grund feines solchen Planes zu besitzen, nach Weiterbildungstyp und Größenklasse
DOI: 10.2908/trng_ent11n
title: Percentage of enterprises without a training plan including CVT, by reason for not having this plan, by type of training and NACE
title: Pourcentage des entreprises sans plan de formation comprenant des cours de formation professionnelle continue, selon la raison de ne pas avoir ce plan, par type de formation et par NACE
title: Prozentsatz der Unternehmen ohne Bildungsplan einschließlich Weiterbildungskursen, nach Grund eines solchen Planes zu besitzen, nach Weiterbildungstyp und NACE
DOI: 10.48597/35uw-htve
title: Measurement of Pm25_mass at Everglades National Park-Research Center (FL11)

description: Measurement of Pm25_mass at Everglades National Park-Research Center (FL11)
DOI: 10.2908/trng_ent12s
title: Enterprises with a training budget including provision for CVT as % of all enterprises, by type of training and size class
title: Entreprises avec un budget de formation comprenant la fourniture de cours de formation professionnelle continue en % de l'ensemble des entreprises, par type de formation et par classe de taille
title: Unternehmen mit einem Bildungsetat einschließlich der Bestimmung für Weiterbildungskursen als Prozentsatz aller Unternehmen, nach Weiterbildungstyp und Größenklasse
DOI: 10.2908/trng_ent13n
title: Enterprises with a training centre used exclusively or partly for CVT as % of all enterprises, by type of training and NACE
title: Entreprises avec un centre de formation utilisé exclusivement ou en partie pour des cours de formation professionnelle continue en % de l'ensemble des entreprises, par type de formation et par NACE
title: Weiterbildungskursen als Prozentsatz aller Unternehmen, nach Weiterbildungstyp und NACE
DOI: 10.48597/3kz6-3fya
title: Measurement of Pm10_mass at Okefenokee National Wildlife Refuge (GA09)

description: Measurement of Pm10_mass at Okefenokee National Wildlife Refuge (GA09)
DOI: 10.2908/trng_ent13s
title: Enterprises with a training centre used exclusively or partly for CVT as % of all enterprises, by type of training and size class
title: Entreprises avec un centre de formation utilisé exclusivement ou en partie pour des cours de formation professionnelle continue en % de l'ensemble des entreprises, par type de formation et par classe de taille
title: Unternehmen mit einem Bildungsmittel ausschließlich oder teils benutzt für Weiterbildungskursen als Prozentsatz aller Unternehmen, nach Weiterbildungstyp und Größenklasse
DOI: 10.2908/trng_ent15n
title: Enterprises evaluating the effect of CVT courses as % of all enterprises providing CVT courses, by NACE
title: L'ensemble des entreprises dispensant des cours de formation professionnelle continue, par NACE
title: Unternehmen, die den Effekt von Weiterbildungskursen auswerten, als Prozentsatz aller Unternehmen, die Weiterbildungskursen bereitstellen, nach NACE